Your HRV is personal and noisy, so read the trend rather than the day

Key takeaways

• In a study of 4,098 Finnish workers, heavy drinking cut overnight heart-rate variability by about 13 milliseconds in the first three hours of sleep, and even small amounts lowered it.
• A review of healthy adults found an average short-term RMSSD, a common HRV measure, of 42 milliseconds, with a reported range of 19 to 75, so your own baseline matters more than anyone else’s number.
• Different wearables measure HRV at different times and in different ways, so readings from two devices aren’t directly comparable.
• Slow-breathing biofeedback cut self-reported stress and anxiety in a 2017 review of 24 studies, but a 2025 review of remote programs found clearer effects on depression than on stress.
• Training by your HRV led to similar fitness gains as a fixed plan in two 2021 reviews, often with fewer hard workouts.

In 2018, Finnish researchers reported on 4,098 employees who wore heart monitors through the night¹. Each person recorded some nights after drinking alcohol and some nights without it. That let the researchers compare each person with themselves.

The results were clear and dose-dependent. After heavy drinking, a measure of heart-rate variability fell by about 13 milliseconds during the first three hours of sleep, and heart rate rose by almost 9 beats per minute¹. Even small amounts of alcohol nudged both numbers in the wrong direction.

Heart-rate variability, or HRV, is the tiny change in timing from one heartbeat to the next. It has become the “readiness” or “recovery” number on many rings, watches and straps. It reflects real biology. It’s also noisy, personal and easy to over-read.

This article covers what HRV measures, what moves it, what breathing practice and training by HRV can and can’t do, and how to read your own trend without worrying over a single morning.

HRV measures the small timing changes between heartbeats

Even at rest, your heart doesn’t beat like a metronome. At 60 beats a minute, the gaps between beats run a little over and under one second, and a healthy body adjusts them constantly.

Much of that adjustment comes from the vagus nerve, the main nerve of the parasympathetic system, which handles “rest and digest” functions. Breathing itself makes heart rate rise and fall slightly³. Higher short-term HRV generally signals more of that calming vagal influence.

In 1996, a joint task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology published standards for measuring HRV²³. Heart research is part of why the number gets attention: among heart attack survivors, higher HRV has been tied to a much lower risk of death³.

Two measures from that tradition show up on consumer devices³:

• RMSSD looks at how much each beat-to-beat gap differs from the next one. It’s the main time-based measure of vagal activity. Many rings and straps report it.
• SDNN is the overall spread of beat-to-beat gaps across a recording. Some Apple Watch data, for example, use SDNN⁵.

Recording length matters. For clinical purposes, 24-hour recordings are the gold standard, and five minutes is the usual short-term standard³. Shorter readings, from 10 seconds to a few minutes, aren’t interchangeable with longer ones.

Age, breathing, fitness, alcohol and illness all move the number

Many things push HRV up or down. Some you can change. Others you can’t.

Age and sex. HRV tends to fall as people age³. In a large pooled analysis, women had lower overall variability than men but more of the breathing-linked, vagal kind³.

Breathing and heart rate. Slower, deeper breathing increases the rhythmic speeding and slowing of the heart³. A faster heart rate, on the other hand, tends to shrink HRV. Posture, movement and recent exercise also change readings.

Fitness and stress. HRV measures tend to be higher in aerobically fit people and lower with poorer health³. Lower readings of the vagal, breathing-linked part of HRV have been tied to stress, anxiety and worry.

Alcohol. The Finnish study showed a stepwise effect¹. Compared with alcohol-free nights, RMSSD fell by about 2 ms after low amounts, 6 ms after moderate amounts and 13 ms after heavy amounts. Two of the study’s authors worked for Firstbeat, the company that made the heart monitors, and the design was observational, so it shows a strong link rather than proof.

Sleep. HRV shifts across the night. As people move from waking into deeper non-REM sleep, vagal activity gradually rises; during REM sleep, the dreaming stage, it falls back⁴. People with insomnia show more “fight or flight” activity during sleep than good sleepers, and untreated sleep apnea pushes the balance the same way⁴.

Illness. In a 2021 study of 297 health care workers wearing Apple Watches, the usual daily rhythm of HRV flattened in those who caught COVID-19, with changes visible up to a week before a positive test⁵. Only 13 people were infected, so the authors called the results preliminary.

That’s the point of the list. A drop could mean a late drink, a cold coming on, a hard workout, a stressful week or a different sleeping position. The number alone can’t tell you which.

Low HRV tracks with heart risk, but that’s a group pattern

A 2013 analysis in Europace pooled eight long-term studies of 21,988 people without known heart disease⁶. Compared with the highest HRV groups, people in the lowest groups had a 32% to 45% higher chance of a first-ever heart or blood vessel event, fatal or not.

The authors were careful about what that means⁶. The link held for all cardiovascular events but not for cardiovascular death alone. None of the pooled studies accounted for physical activity or breathing, which both affect HRV. And the finding showed an association across groups, so whether HRV can flag risk for one person is still untested.

Low HRV may be a marker of other things, such as low fitness or poor health, rather than a cause of disease. These studies don’t show that raising your number lowers your heart risk.

There’s also a twist: higher isn’t always better³. Some heart rhythm problems, including atrial fibrillation, an irregular and often fast rhythm, can make variability look high. A wearable may read that chaos as “good” HRV.

Your device’s HRV depends on what it measures and when

A chest strap reads the heart’s electrical signal, much like an electrocardiogram (ECG). Rings and watches use light sensors that detect pulses of blood under the skin. In one comparison cited in a 2017 review, the two methods differed by less than 6% for most HRV measures, though one differed by about 30%³.

Timing differs too. A 2022 Australian lab study compared six devices with ECG in 53 healthy young adults⁷. Every device underestimated HRV on average. WHOOP agreed with ECG almost perfectly, and the Apple Watch, Polar, Oura and Somfit devices showed good agreement.

Garmin’s agreement was poor, possibly because its reading came from a three-minute test while awake before bed, not during sleep⁷.

Two cautions apply. WHOOP and Somfit supplied raw data for the researchers to analyze, while the other brands’ figures came from their own formulas, and the authors’ research group receives funding and equipment from WHOOP⁷. Several devices also overestimated low HRV and underestimated high HRV.

A 2025 study followed 13 adults over 536 nights⁸. Compared with ECG, average HRV errors ranged from about 6% for the newest Oura ring to about 16% for a Polar watch, with the older Oura, WHOOP and Garmin in between.

The practical lessons:

• Don’t compare your number with a friend’s on a different device.
• If you switch devices, expect a new baseline.
• Software updates and new models can change results, so these rankings may not hold for today’s versions.

HRV biofeedback: slow breathing with a screen

HRV biofeedback trains you to breathe slowly while watching your heart rhythm on a screen. The goal is a breathing pace that makes heart rate rise and fall in large, smooth waves. Breathing at about 4.5 to 7.5 breaths a minute does this, and six a minute is a common target³.

Slow, steady breathing will feel familiar to anyone who practices yoga breathing, meditation or rhythmic prayer. Biofeedback adds a live readout and a way to measure the effect.

The research is encouraging, with caveats:

• A 2017 Boston University review of 24 studies with 484 people found a large drop in self-reported stress and anxiety after biofeedback training⁹. The authors said better-controlled studies are needed.
• A 2020 review of 58 studies found small to moderate benefits overall, largest for anxiety, depression, anger and athletic or artistic performance, and smallest for PTSD, sleep and quality of life¹⁰. Benefits were larger against no treatment than against other active treatments.
• A 2025 review of remote, mostly at-home programs pooled 18 studies with 1,352 people¹¹. Biofeedback eased depression symptoms moderately and raised HRV, but effects on stress, anxiety and sleep were inconclusive. Only one study had a low risk of bias, and more people dropped out of the biofeedback groups.

Put together, HRV biofeedback is a reasonable complement for stress and low mood. It isn’t a substitute for treatment of an anxiety disorder or depression.

Training by HRV gave similar gains with fewer hard days

Many athletes now let a morning HRV reading decide whether to push hard or go easy. Two 2021 reviews tested that idea against fixed training plans.

The first pooled eight studies with 199 mostly young, healthy adults¹². Training by HRV didn’t produce significantly better aerobic fitness or endurance performance. It may have helped people keep their vagal HRV up and led to fewer people responding poorly to training. Seven of the eight studies measured HRV in the morning after waking.

The second, also eight studies with 198 people, found that HRV-guided programs usually included fewer moderate or hard sessions than fixed plans¹³. Performance and peak oxygen use came out about the same, while some measures taken during moderate effort improved more. HRV guidance also produced fewer people who failed to respond.

In plain terms, letting HRV guide your hard days won’t make you fitter than a sensible plan. It may get you there with less strain. Studies were small and lasted two to eight weeks, so the long-term picture is unclear¹².

How to read your HRV: a four-week routine

The research points one way: compare yourself with yourself, over time.

Week 1 to 2: build a baseline.
1. Pick one method and stick with it: either your device’s overnight average or a short morning reading taken right after waking, in the same position each time. Most training studies used morning readings¹².
2. Don’t judge any single day yet. Note anything unusual, such as alcohol, illness, travel or a hard workout.

Week 3 onward: watch the rolling average.
3. Look at your seven-day average, not today’s number. Several training studies compared a seven-day average with each person’s own baseline¹².
4. Learn your normal band. Some studies treated a day as low only when it fell below a set margin under the person’s average, such as half or one standard deviation¹².
5. When your average drifts low for several days, check the usual suspects: alcohol¹, a brewing illness⁵, heavy training, poor sleep or stress³⁴.
6. Respond gently. Try an easier workout, an earlier night or a few alcohol-free days, then watch whether the trend recovers.

What you see	Possible reasons	What to try
One low morning	Late drink, poor night, position change, noise	Nothing; wait for the trend
Several low days in a row	Hard training block, illness starting, stress, alcohol	Ease off, rest, skip alcohol, watch for symptoms
Slow rise over weeks	Better fitness, steadier sleep, less drinking	Keep doing what’s working
Sudden high or erratic readings	Irregular rhythm or poor sensor contact	Check fit; see a clinician if you have symptoms
Big jump after a new device or update	Different sensor or formula	Start a fresh baseline

The evidence at a glance

Claim	Evidence level	What the research shows
HRV reflects nervous-system activity	Strong evidence	Decades of standards and research; RMSSD mainly reflects vagal activity23
Alcohol lowers overnight HRV	Strong evidence	Dose-dependent drop in 4,098 workers compared with their own sober nights1
Groups with low HRV have higher heart disease risk	Strong evidence	32% to 45% higher risk of first event in pooled cohorts; not proof of cause or individual prediction6
Wearables measure HRV accurately	Promising but early	Good agreement for some devices, poor for others; small studies78
HRV biofeedback eases stress and anxiety	Promising but early	Large effect in a 2017 review; inconclusive for remote programs in 2025911
HRV biofeedback eases depression symptoms	Promising but early	Moderate effects in pooled trials, many at risk of bias1011
HRV-guided training beats a fixed plan for fitness	Evidence says no	Similar fitness and performance in two reviews, with fewer hard sessions1213
HRV changes can flag illness early	Not enough evidence	One small study with 13 infections5

When an HRV reading needs a clinician

HRV is a wellness measure, not a diagnosis. Under the FDA’s January 2026 guidance, products that claim to help you “manage stress” or that show trends from light-based sensors can fall in a low-risk wellness category the agency says it does not intend to examine¹⁵. The line is crossed when a product claims to diagnose a disease.

A strange HRV reading by itself isn’t an emergency. Symptoms are what matter. MedlinePlus, from the National Library of Medicine, advises calling 911 if heart palpitations come with fainting, chest pain, shortness of breath, unusual sweating, or dizziness¹⁴.

Contact a clinician right away if¹⁴:

• You often feel extra or skipped beats.
• Your resting pulse is over 100 without exercise, anxiety or fever.
• Your palpitations are new or different.
• You have heart disease or risk factors such as diabetes or high blood pressure.

Also tell a clinician if your device shows erratic or unusually high HRV along with an irregular-feeling pulse. That pattern can come from rhythm problems rather than good health³.

Questions readers ask

The bottom line

HRV is a real window into how your nervous system is coping. It responds to the things natural-health readers already care about: movement, rest, moderation with alcohol and calm breathing. That makes it a useful mirror for habits.

It’s also a noisy, personal number that varies with devices and formulas. Read the weekly trend against your own baseline, treat breathing biofeedback as a helpful practice rather than a cure, and let symptoms, not a score, decide when you need a clinician.

Related reading

• “FDA registered” isn’t “FDA approved”: a buyer’s map to wellness devices
• Why being out of range often means nothing at all
• Tai chi, prayer and journaling: what research can measure and what it can’t
• The symptoms that mean call 911 now

Sources

1. Pietilä J, Helander E, Korhonen I, Myllymäki T, Kujala UM, Lindholm H. “Acute Effect of Alcohol Intake on Cardiovascular Autonomic Regulation During the First Hours of Sleep in a Large Real-World Sample of Finnish Employees: Observational Study.” JMIR Mental Health, 2018. pubmed.ncbi.nlm.nih.gov
2. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (Malik M, Bigger JT, Camm AJ, et al.). “Heart rate variability: Standards of measurement, physiological interpretation, and clinical use.” European Heart Journal, 1996. doi.org
3. Shaffer F, Ginsberg JP. “An Overview of Heart Rate Variability Metrics and Norms.” Frontiers in Public Health, 2017. frontiersin.org
4. Tobaldini E, Nobili L, Strada S, Casali KR, Braghiroli A, Montano N. “Heart rate variability in normal and pathological sleep.” Frontiers in Physiology, 2013. frontiersin.org
5. Hirten RP, Danieletto M, Tomalin L, et al. “Use of Physiological Data From a Wearable Device to Identify SARS-CoV-2 Infection and Symptoms and Predict COVID-19 Diagnosis: Observational Study.” Journal of Medical Internet Research, 2021. pubmed.ncbi.nlm.nih.gov
6. Hillebrand S, Gast KB, de Mutsert R, et al. “Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression.” Europace, 2013. pubmed.ncbi.nlm.nih.gov
7. Miller DJ, Sargent C, Roach GD. “A Validation of Six Wearable Devices for Estimating Sleep, Heart Rate and Heart Rate Variability in Healthy Adults.” Sensors, 2022. pubmed.ncbi.nlm.nih.gov
8. Dial MB, Hollander ME, Vatne EA, Emerson AM, Edwards NA, Hagen JA. “Validation of nocturnal resting heart rate and heart rate variability in consumer wearables.” Physiological Reports, 2025 (abstract via CiteDrive). citedrive.com
9. Goessl VC, Curtiss JE, Hofmann SG. “The effect of heart rate variability biofeedback training on stress and anxiety: a meta-analysis.” Psychological Medicine, 2017. cambridge.org
10. Lehrer P, Kaur K, Sharma A, et al. “Heart Rate Variability Biofeedback Improves Emotional and Physical Health and Performance: A Systematic Review and Meta Analysis.” Applied Psychophysiology and Biofeedback, 2020. link.springer.com
11. Vann-Adibe S, Tsui HKH, Zhou HQ, et al. “Efficacy and Methodology of Remote Heart Rate Variability Biofeedback Interventions for Mental Health: A Systematic Review and Meta-Analysis.” Applied Psychophysiology and Biofeedback, 2025. link.springer.com
12. Manresa-Rocamora A, Sarabia JM, Javaloyes A, Flatt AA, Moya-Ramón M. “Heart Rate Variability-Guided Training for Enhancing Cardiac-Vagal Modulation, Aerobic Fitness, and Endurance Performance: A Methodological Systematic Review with Meta-Analysis.” International Journal of Environmental Research and Public Health, 2021. mdpi-res.com
13. Düking P, Zinner C, Trabelsi K, et al. “Monitoring and adapting endurance training on the basis of heart rate variability monitored by wearable technologies: A systematic review with meta-analysis.” Journal of Science and Medicine in Sport, 2021 (abstract via BISp database). lida.sport-iat.de
14. MedlinePlus. “Heart palpitations.” U.S. National Library of Medicine, reviewed June 2026. medlineplus.gov
15. U.S. Food and Drug Administration. “General Wellness: Policy for Low Risk Devices.” Final guidance, January 2026. fda.gov